Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pien Tze Huang Capsule for diabetic foot ulcer
ChiCTR2100041962Phase 4Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Feb 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of Pien Tze Huang in diabetic foot ulcer (DFU) (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Target ulcer wound healing rate at 12 weeks. Started Feb 2021; status: recruiting.
02
Drugs
Pien Tze Huang
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on ChiCTR2100041962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041962.